Alaunos Therapeutics (TCRT) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Alaunos Therapeutics (TCRT) over the last 15 years, with Q2 2025 value amounting to $2000.0.
- Alaunos Therapeutics' Receivables - Net fell 5000.0% to $2000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $2000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $5000.0 for FY2024, which is 40000.0% up from last year.
- Per Alaunos Therapeutics' latest filing, its Receivables - Net stood at $2000.0 for Q2 2025, which was down 5000.0% from $2000.0 recorded in Q1 2025.
- Alaunos Therapeutics' 5-year Receivables - Net high stood at $7.6 million for Q2 2021, and its period low was $1000.0 during Q4 2023.
- Over the past 5 years, Alaunos Therapeutics' median Receivables - Net value was $4000.0 (recorded in 2022), while the average stood at $1.4 million.
- As far as peak fluctuations go, Alaunos Therapeutics' Receivables - Net soared by 54015.35% in 2021, and later plummeted by 9964.0% in 2022.
- Quarter analysis of 5 years shows Alaunos Therapeutics' Receivables - Net stood at $1.1 million in 2021, then crashed by 99.64% to $4000.0 in 2022, then crashed by 75.0% to $1000.0 in 2023, then surged by 400.0% to $5000.0 in 2024, then tumbled by 60.0% to $2000.0 in 2025.
- Its last three reported values are $2000.0 in Q2 2025, $2000.0 for Q1 2025, and $5000.0 during Q4 2024.